Zhejiang Huahai Pharmaceutical Co., Ltd. Class ASSE: 600521

"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Pledge of Certain Shares Held by the Shareholder

Sep 11, 2026 · Issued by Zhejiang Huahai Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Filed with SSE · Sep 11, 2026

Announcement on Pledge of Certain Shares Held by the Shareholder

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Company analysis

Earlier from Zhejiang Huahai Pharmaceutical Co., Ltd. Class A

Hansoh Pharmaceutical: BIOLOGICS LICENSE APPLICATION OF RISVUTATUG REZETCAN (HS-20093) FOR INJECTION FOR SMALL CELL LUNG CANCER ACCEPTED BY THE NMPASep 7
"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Semi-annual Report for 2026Aug 27
"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Subsidiary Passing the Drug GMP Compliance InspectionAug 20
"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on the Proposed Selection of the Company's Products in the 12th Batch of National Centralized Drug ProcurementAug 3

All Zhejiang Huahai Pharmaceutical Co., Ltd. Class A news releases